{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:34:47Z","timestamp":1780418087035,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijcha.2021.100830","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T21:59:00Z","timestamp":1624571940000},"page":"100830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Elevated resting heart rate is a marker of subclinical left ventricular dysfunction in hodgkin lymphoma survivors"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6892-5227","authenticated-orcid":false,"given":"Julius C.","family":"Heemelaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3257-3634","authenticated-orcid":false,"given":"Augustinus D.G.","family":"Krol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6748-3540","authenticated-orcid":false,"given":"Marloes","family":"Louwerens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"L.M.A. Beeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard R.","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Schalij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2021.100830_b0005","unstructured":"Nederlandse Kanker Registratie (NKR) [Internet]. Intergraal Kankercentrum Nederland (IKNL). [cited July 16th 2020]. Available from: www.iknl.nl."},{"issue":"6","key":"10.1016\/j.ijcha.2021.100830_b0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med."},{"issue":"23","key":"10.1016\/j.ijcha.2021.100830_b0015","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2013.01.090","article-title":"Cardiac Complications of Thoracic Irradiation","volume":"61","author":"Jaworski","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcha.2021.100830_b0020","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin's disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100830_b0025","doi-asserted-by":"crossref","first-page":"608","DOI":"10.6004\/jnccn.2017.0064","article-title":"Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Hoppe","year":"2017","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"36","key":"10.1016\/j.ijcha.2021.100830_b0030","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehw359","article-title":"An ESC position paper on cardio-oncology","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2021.100830_b0035","article-title":"Richtlijn follow -up na kinderkanker: meer dan 5 jaar na diagnose","author":"SKION","year":"2010","journal-title":"Deel 1."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100830_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ppedcard.2015.10.006","article-title":"Peak oxygen consumption in Hodgkin's lymphoma survivors treated with mediastinal radiotherapy as a predictor of quality of life 5 years later","volume":"39","author":"Adams","year":"2015","journal-title":"Progress in Pediatric Cardiology."},{"issue":"12","key":"10.1016\/j.ijcha.2021.100830_b0045","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/ejhf.670","article-title":"Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study","volume":"18","author":"Anker","year":"2016","journal-title":"Eur. J. Heart Fail"},{"issue":"8","key":"10.1016\/j.ijcha.2021.100830_b0050","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2105\/AJPH.91.8.1258","article-title":"Heart Rate as a Predictor of Mortality: The MATISS Project","volume":"91","author":"Seccareccia","year":"2001","journal-title":"Am. J. Public Health"},{"issue":"6","key":"10.1016\/j.ijcha.2021.100830_b0055","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: The Framingham study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.ijcha.2021.100830_b0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/eurheartj\/ehr293","article-title":"Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention","volume":"33","author":"Antoni","year":"2011","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcha.2021.100830_b0065","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.amjcard.2008.01.021","article-title":"Relation of Heart Rate Parameters During Exercise Test to Sudden Death and All-Cause Mortality in Asymptomatic Men","volume":"101","author":"Adabag","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2021.100830_b0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jjcc.2013.02.018","article-title":"Heart rate: a global target for cardiovascular disease and therapy along the cardiovascular disease continuum","volume":"62","author":"Custodis","year":"2013","journal-title":"J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2021.100830_b0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/oxfordjournals.aje.a113213","article-title":"Heart rate: a risk factor for cancer?","volume":"114","author":"Persky","year":"1981","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.ijcha.2021.100830_b0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jacc.2014.11.035","article-title":"Abnormal exercise response in long-term survivors of hodgkin lymphoma treated with thoracic irradiation: evidence of cardiac autonomic dysfunction and impact on outcomes","volume":"65","author":"Groarke","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.ijcha.2021.100830_b0085","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2014.07.948","article-title":"Cardiovascular Function and Predictors of Exercise Capacity in Patients With Colorectal Cancer","volume":"64","author":"Cramer","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100830_b0090","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ahj.2004.12.026","article-title":"Diastolic dysfunction after mediastinal irradiation","volume":"150","author":"Heidenreich","year":"2005","journal-title":"Am. Heart J."},{"issue":"10","key":"10.1016\/j.ijcha.2021.100830_b0095","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2004.06.033","article-title":"Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults","volume":"22","author":"Hequet","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.ijcha.2021.100830_b0100","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","article-title":"Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy","volume":"22","author":"Adams","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.ijcha.2021.100830_b0105","first-page":"2511","article-title":"Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer","volume":"65","author":"Armstrong","year":"2015","journal-title":"Results From the St Jude Lifetime Cohort Study"},{"issue":"1","key":"10.1016\/j.ijcha.2021.100830_b0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.CIR.95.1.169","article-title":"Increased Cardiac Adrenergic Drive Precedes Generalized Sympathetic Activation in Human Heart Failure","volume":"95","author":"Rundqvist","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcha.2021.100830_b0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. \u2013 Cardiovasc. Imaging"},{"issue":"12","key":"10.1016\/j.ijcha.2021.100830_b0120","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur. Heart J. \u2013 Cardiovasc. Imaging"},{"issue":"10","key":"10.1016\/j.ijcha.2021.100830_b0125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"36","key":"10.1016\/j.ijcha.2021.100830_b0130","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.ijcha.2021.100830_b0135","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jacc.2016.12.037","article-title":"A Test in Context: E\/A and E\/e' to Assess Diastolic Dysfunction and LV Filling Pressure","volume":"69","author":"Mitter","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2021.100830_b0140","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjcard.2010.09.048","article-title":"Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy","volume":"107","author":"Tsai","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcha.2021.100830_b0145","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1080\/0284186X.2019.1630751","article-title":"Adjuvant radiotherapy-induced cardiac changes among patients with early breast cancer: a three-year follow-up study","volume":"58","author":"Skytt\u00e4","year":"2019","journal-title":"Acta Oncol."},{"issue":"3","key":"10.1016\/j.ijcha.2021.100830_b0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/ehjci\/jes139","article-title":"Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy","volume":"14","author":"Stoodley","year":"2013","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"16","key":"10.1016\/j.ijcha.2021.100830_b0155","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.ejca.2013.06.046","article-title":"Left ventricular systolic function in HER2\/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months","volume":"49","author":"Stoodley","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.ijcha.2021.100830_b0160","doi-asserted-by":"crossref","first-page":"e21310","DOI":"10.1371\/journal.pone.0021310","article-title":"Heart Rate and Risk of Cancer Death in Healthy Men","volume":"6","author":"Jouven","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijcha.2021.100830_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1782","article-title":"Increased resting heart rate and prognosis in treatment-na\u00efve unselected cancer patients: results from a prospective observational study: Resting heart rate in cancer","author":"Anker","year":"2020","journal-title":"Eur. J. Heart Fail"},{"issue":"5","key":"10.1016\/j.ijcha.2021.100830_b0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9149(90)90298-F","article-title":"Effect of postural stimulation on systemic hemodynamics and sympathetic nervous activity in systemic hypertension","volume":"65","author":"Izzo","year":"1990","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcha.2021.100830_b0175","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/00004872-199816110-00010","article-title":"Heart rate as marker of sympathetic activity","volume":"16","author":"Grassi","year":"1998","journal-title":"J. Hypertens"},{"issue":"9","key":"10.1016\/j.ijcha.2021.100830_b0180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.ijcha.2021.100830_b0185","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00432-014-1658-7","article-title":"Meta-analysis of the effects of beta blocker on survival time in cancer patients","volume":"140","author":"Choi","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100830_b0190","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/CEJ.0000000000000192","article-title":"\u03b2-Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies","volume":"25","author":"Zhong","year":"2016","journal-title":"Eur. J. Cancer Prev."},{"issue":"11","key":"10.1016\/j.ijcha.2021.100830_b0195","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ajh.21840","article-title":"Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up","volume":"85","author":"Georgakopoulos","year":"2010","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.ijcha.2021.100830_b0200","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","article-title":"Protective effects of carvedilol against anthracycline-induced cardiomyopathy","volume":"48","author":"Kalay","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcha.2021.100830_b0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/FJC.0000000000000470","article-title":"Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity","volume":"69","author":"Nabati","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100830_b0210","first-page":"78","article-title":"The effects of exercise training on maximum aerobic capacity, resting heart rate, blood pressure and anthropometric variables of postmenopausal women with breast cancer","volume":"15","author":"Rahnama","year":"2010","journal-title":"J. Res. Med. Sci."},{"issue":"8","key":"10.1016\/j.ijcha.2021.100830_b0215","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.mayocp.2014.03.018","article-title":"The effect of resistance exercise on all-cause mortality in cancer survivors","volume":"89","author":"Hardee","year":"2014","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.ijcha.2021.100830_b0220","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2010.31.5226","article-title":"Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study","volume":"29","author":"Kenfield","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"10203","key":"10.1016\/j.ijcha.2021.100830_b0225","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"The Lancet"},{"issue":"48","key":"10.1016\/j.ijcha.2021.100830_b0230","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcha.2021.100830_b0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.adro.2016.04.002","article-title":"Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging","volume":"1","author":"Huang","year":"2016","journal-title":"Adv. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.ijcha.2021.100830_b0240","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/jcm8040421","article-title":"Phasic Left Atrial Function in Cancer Patients Before Initiation of Anti-Cancer Therapy","volume":"8","author":"Tadic","year":"2019","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.ijcha.2021.100830_b0245","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcha.2021.100830_b0250","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ijcha.2021.100830_b0255","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2012.46.6854","article-title":"American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care","volume":"31","author":"McCabe","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.ijcha.2021.100830_b0260","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines","volume":"129","author":"van Nimwegen","year":"2017","journal-title":"Blood"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721001184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906721001184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:11:37Z","timestamp":1762492297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906721001184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":52,"alternative-id":["S2352906721001184"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100830","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated resting heart rate is a marker of subclinical left ventricular dysfunction in hodgkin lymphoma survivors","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2021.100830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100830"}}